CEO Alex Wasyl of Nexien BioPharma, Inc. (OTCQB: NXEN) joins Stock Day to discuss recent acquisition, consolidation, and being engaged in the formulation, development, and commercialization of cannabinoid based drugs.

OTCQB: NXEN # pharmaceutical company # cannabinoid-based pharmaceuticals # U.S. Food and Drug Administration # Colorado # drug development strategy # FDA protocols # formerly INTIVA BioPharma # healthcare # Intellectual Property # Medical Marijuana # pre-clinical and clinical pathways